idazoxan has been researched along with arginine in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bryan, RM; Childres, WF; Eichler, MY; Johnson, TD; Suresh, MS; Swafford, MW | 1 |
| Feinstein, DL; Regunathan, S; Reis, DJ | 1 |
| Ferguson, TB; Johnson, FK; Johnson, RA; Joshi, MS; Lancaster, JR; Parthasarathy, S | 1 |
| Chopde, CT; Gahane, AY; Kotagale, NR; Taksande, BG; Ugale, RR | 1 |
| Aglawe, MM; Chopde, CT; Kotagale, NR; Taksande, BG; Tripathi, SJ; Umekar, MJ | 1 |
| Aglawe, MM; Chopde, CT; Gujar, S; Khade, SD; Kotagale, NR; Taksande, BG | 1 |
6 other study(ies) available for idazoxan and arginine
| Article | Year |
|---|---|
Stimulation of alpha 2 adrenoceptors dilates the rat middle cerebral artery.
Topics: Animals; Arginine; Brimonidine Tartrate; Cerebral Arteries; Cerebrovascular Circulation; Dioxanes; Dose-Response Relationship, Drug; GTP-Binding Proteins; Idazoxan; Imidazoles; Male; NG-Nitroarginine Methyl Ester; Quinoxalines; Rats; Receptors, Adrenergic, alpha-2; Vasodilation | 1996 |
Inhibition of astroglial nitric oxide synthase type 2 expression by idazoxan.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Animals, Newborn; Arginine; Astrocytes; Cell Line; Cell-Free System; Chloramphenicol O-Acetyltransferase; Citrulline; Cytokines; Dose-Response Relationship, Drug; Gene Expression Regulation, Enzymologic; Idazoxan; Lipopolysaccharides; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Nitrites; Norepinephrine; Promoter Regions, Genetic; Rats; Rats, Sprague-Dawley; Recombinant Fusion Proteins; RNA, Messenger; Time Factors; Tumor Cells, Cultured | 1999 |
Receptor-mediated activation of nitric oxide synthesis by arginine in endothelial cells.
Topics: Adrenergic alpha-Antagonists; Agmatine; Aniline Compounds; Arginine; Calcium; Calcium Channel Blockers; Cell Culture Techniques; Cells, Cultured; Culture Media, Serum-Free; Dexmedetomidine; Dose-Response Relationship, Drug; Endothelial Cells; Endothelium, Vascular; Enzyme Activation; Estrenes; Fluorescent Dyes; Humans; Idazoxan; Imidazolines; Lipopolysaccharides; Molecular Structure; NG-Nitroarginine Methyl Ester; Nifedipine; Nitrates; Nitric Oxide; Nitric Oxide Synthase Type III; Nitrites; Pyrrolidinones; Receptors, Adrenergic, alpha-2; Second Messenger Systems; Type C Phospholipases; Umbilical Veins; Virulence Factors, Bordetella; Xanthenes; Yohimbine | 2007 |
Repeated agmatine treatment attenuates nicotine sensitization in mice: modulation by alpha2-adrenoceptors.
Topics: Agmatine; Animals; Arginine; Biguanides; Clonidine; Dose-Response Relationship, Drug; Drug Interactions; Eflornithine; Enzyme Inhibitors; Guanidines; Idazoxan; Male; Mice; Motor Activity; Nicotine; Receptors, Adrenergic, alpha-2; Yohimbine | 2010 |
Evidences for the agmatine involvement in antidepressant like effect of bupropion in mouse forced swim test.
Topics: Agmatine; Animals; Antidepressive Agents; Arginine; Benzofurans; Biguanides; Bupropion; Clonidine; Dose-Response Relationship, Drug; Drug Interactions; Eflornithine; Guanidines; Idazoxan; Imidazoles; Immobility Response, Tonic; Injections, Intraventricular; Male; Mice; Motor Activity | 2013 |
Agmatine Inhibits Behavioral Sensitization to Ethanol Through Imidazoline Receptors.
Topics: Agmatine; Animals; Arginine; Benzofurans; Biguanides; Central Nervous System Sensitization; Dose-Response Relationship, Drug; Drug Interactions; Ethanol; Guanidines; Idazoxan; Imidazoles; Imidazoline Receptors; Infusions, Intraventricular; Male; Mice; Microinjections; Motor Activity | 2019 |